Advanced Medical Solutions Group PLC

Advanced Medical Solutions Group PLC (LSE: AMS) is an FTSE AIM UK 50 Index-listed Company engaged in designing, manufacturing, and developing surgical equipment and advanced wound care products

Trading Update (Released on 04 September 2023)

• Organogenesis US: During August 2023, Organogenesis announced that there was some modification related to the US reimbursement coverage for the treatment of diabetic foot ulcers and venous leg ulcers, which created certain uncertainty regarding a few of the products especially those consumed across AMS patents.  
• Revenue Forecast: The company estimated the revenues to be between GBP 124 mn and GBP 127 mn and the adjusted profit could range from GBP 124 mn to GBP 127 mn for FY23.
• Adjusted Profit Outlook: The management revised the adjusted pre-tax profit downward by GBP 2 mn, on grounds related to the Organogenesis US concerns. On account of the removal of the royalty, the adjusted pre-tax profit could be declined by GBP 4 mn per year for FY24 & FY25, which may extend to FY26 (September end as per the agreement).  

Share Price Chart

Markets are trading in a highly volatile zone currently due to certain macroeconomic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Advanced Medical Solutions Group PLC (LSE: AMS) was trading at the current market price of GBX 178.20 (as of 06 September 2023, 11:00 AM GMT+1)  

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is 06 September 2023. The reference data in this report has been partly sourced from REFINITIV.

Note 3: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

Note 4: Dividend Yield may vary as per the stock price movement.

Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.